Evaluation of the usefulness of six commercial agglutination assays for serologic diagnosis of toxoplasmosis

Diagnostic Microbiology and Infectious Disease

Volumn 73, Issue 3, 2012, Pages 231-235

  Villard, Odile ^a   Cimon, Bernard ^b   Franck, Jacqueline ^c   Fricker Hidalgo, Hélène ^d   Godineau, Nadine ^e   Houze, Sandrine ^f   Paris, Luc ^g   Pelloux, Hervé ^d   Villena, Isabelle ^h   Candolfi, Ermanno ^a   Totet, A ⁱ   Cimon, B ^b   Scherer, E ^j   Accoceberry, I ^k   Nevez, G ^l   Quinio, D ^l   Bonhomme, J ^m   Carme, B ⁿ   Demar, M ⁿ   Bonnin, A ^o   Cuisenier, B ^o   Dalle, F ^o   Desbois, N ^j   Brenier Pinchart, M P ^p   Fricker Hidalgo, H ^p   Pelloux, H ^p   Delhaes, L ^q   Ajzenberg, D ^r   Darde M L ^r   Franck, J ^s   Piarroux, R ^s   Bastien, P ^t   Sterkers, Y ^t   Pratlong, F ^t   Machouart, M ^u   Leterrier, M ^v   Morio, F ^v   Ferret, N ^w   Pomares, C ^w   Marty, P ^w   Angoulvant, A ^x   Houze, S ^y   Ancelle, T ^y   Yera, H ^y   Derouin, F ^y   Menotti, J ^y   Bougnoux, M E ^y   Hassouni, N ^y   Touafek, F ^y   Paris, L ^y   Godineau, N ^z   Roux, P ^y   Hennequin, C ^y   Azi, S ^aa   Berthonneau, J ^ab   Aubert, D ^ac   Chemla, C ^ac   Villena, I ^ac   Robert Gangneux, F ^ad   Favennec, L ^ae   Gargala, G ^ae   Flori, P ^af   Candolfi, E ^ag   Filisetti, D ^ag   Villard, O ^ag   Filiaux, J ^ah   Cassaing, S ^ah   Vanlangendonck, N ^ai   more..

^a UNIVERSITY HOSPITAL OF STRASBOURG   (France)

^b ANGERS UNIVERSITY HOSPITAL   (France)

^c TIMONE HOSPITAL   (France)

^d UNIV GRENOBLE ALPES   (France)

^e Centre Hospitalier de Saint Denis   (France)

^f BICHAT HOSPITAL   (France)

^g ASSISTANCE PUBLIQUE HÔPITAUX DE PARIS   (France)

^h HÔPITAL MAISON BLANCHE   (France)

ⁱ Hospital and University Centre   (France)

^j Hospital and University Centre   (France)

^k Hospital and University Centre   (France)

^l Hospital and University Centre   (France)

^m University Hospitals   (France)

ⁿ Hospital and University Centre   (France)

^o DIJON UNIVERSITY HOSPITAL   (France)

^p Hospital and University Centre   (France)

^q Hospital and University Centre   (France)

^r Hospital and University Centre   (France)

^s Hospital and University Centre   (France)

^t MONTPELLIER UNIVERSITY HOSPITAL   (France)

^u Hospital and University Centre   (France)

^v NANTES UNIVERSITY HOSPITAL   (France)

^w UNIVERSITY HOSPITAL OF NICE   (France)

^x Hospital and University Centre   (France)

^y Hospital and University Centre   (France)

^z Hospital and University Centre   (France)

^aa Hospital and University Centre   (France)

^ab Hospital and University Centre   (France)

^ac Hospital and University Centre   (France)

^ad Hospital and University Centre   (France)

^ae Hospital and University Centre   (France)

^af Hospital and University Centre   (France)

^ag Hospital and University Centre   (France)

^ah TOULOUSE UNIVERSITY HOSPITAL   (France)

^ai Laboratory of Hemostasis Trousseau University Hospital   (France)

more..

Author keywords

Agglutination tests; Serologic diagnosis; Toxoplasma gondii; Toxoplasmosis

Indexed keywords

IMMUNOGLOBULIN G ANTIBODY; IMMUNOGLOBULIN M ANTIBODY;

AGGLUTINATION TEST; ANTIBODY DETECTION; ARTICLE; CONTROLLED STUDY; DIAGNOSTIC TEST ACCURACY STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FALSE POSITIVE RESULT; HUMAN; IMMUNOFLUORESCENCE TEST; LABORATORY DEVICE; LIMIT OF DETECTION; MAJOR CLINICAL STUDY; PREDICTIVE VALUE; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY; SERODIAGNOSIS; TOXOPLASMA GONDII; TOXOPLASMOSIS;

AGGLUTINATION TESTS; ANTIBODIES, PROTOZOAN; DIAGNOSTIC ERRORS; HUMANS; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; SENSITIVITY AND SPECIFICITY; SEROLOGIC TESTS; TOXOPLASMA; TOXOPLASMOSIS;

EID: 84862188530     PISSN: 07328893     EISSN: 18790070     Source Type: Journal    
DOI: 10.1016/j.diagmicrobio.2012.03.014     Document Type: Article

References (35)

1. Ancelle T., Goulet V., Tirard-Fleury V., Baril L., du Mazaubrun C., Thuillez P. La toxoplasmose chez la femme enceinte en France en 1995. Résultats d'une enquête nationale périnatale. Bull Epidemiol Hebdo 1996, 51:227-229.
2. Ancelle T., Yera H., Talabani H., Lebuisson A., Thuillez P., Dupouy-Camet J. How to reduce the costs of screening for toxoplasmosis in pregnant women?. Rev Epidemiol Sante Publique 2009, 57:411-417.
3. Berger F., Goulet V., Le Strat Y., Desenclos J.C. Toxoplasmose chez la femme enceinte en France: évolution de la séroprévalence et de l'incidence et facteurs associés, 1995-2003. BEH 2008, 14-15:117-124. (article in French).
4. Candolfi E., Pastor R., Huber R., Filisetti D., Villard O. IgG avidity assay firms up the diagnosis of acute toxoplasmosis on the first serum sample in immunocompetent pregnant women. Diagn Microbiol Infect Dis 2007, 58:83-88.
5. Cortina-Borja M., Tan H.K., Wallon M., Paul M., Prusa A., Buffolano W., et al. Prenatal treatment for serious neurological sequelae of congenital toxoplasmosis: an observational prospective cohort study. PLoS Med 2010, 7.
6. Cozon G.J., Ferrandiz J., Nebhi H., Wallon M., Peyron F. Estimation of the avidity of immunoglobulin G for routine diagnosis of chronic Toxoplasma gondii infection in pregnant women. Eur J Clin Microbiol Infect Dis 1998, 17:32-36.
7. Desmonts G., Cousin L. Technique de l'épreuve de lyse des toxoplasmes. Feuillets de Biologie IV 1963, 9-16.
8. Duffy K.T., Wharton P.J., Johnson J.D., New L., Holliman R.E. Assessment of immunoglobulin-M immunosorbent agglutination assay (ISAGA) for detecting toxoplasma specific IgM. J Clin Pathol 1989, 42:1291-1295.
9. Dunford P., Johnson J. Detection of toxoplasma-specific immunoglobulin-G: assessment of a slide agglutination test. Med Lab Sci 1991, 48:137-141.
10. Evans R., Ho-Yen D.O. Evidence-based diagnosis of toxoplasma infection. Eur J Clin Microbiol Infect Dis 2000, 19:829-833.
11. FDA. Guidance for industry and FDA staff. Statistical Guidance on Reporting Results from Studies Evaluating Diagnostic Tests. 5630 Fishers Lane, Room 1061, (HFA-305), Rockville, MD, 20852. 1-39.
12. Flori P., Chene G., Varlet M.N., Sung R.T. Toxoplasma gondii serology in pregnant woman: characteristics and pitfalls. Ann Biol Clin (Paris) 2009, 67:125-133.
13. Fourlinnie J.C., Guffroy R., Herbaut J.C., Labarthe A. Optimisation du dépistage des anticorps antitoxoplasmiques IgG et IgM par l'association d'une réaction d'hémagglutination indirecte et d'un test au latex standardisé sur plaque de kline. Feuillets de Biologie 1985, XXVI:45-49.
14. Franck J., Garin Y.J., Dumon H. LDBio-Toxo II immunoglobulin G Western blot confirmatory test for anti-toxoplasma antibody detection. J Clin Microbiol 2008, 46:2334-2338.
15. Garcia-Meric P., Franck J., Dumon H., Piarroux R. Prise en charge de la toxoplasmose congénitale. Presse Med 2010, 39:510-538.
16. Gilbert R., Gras L. Effect of timing and type of treatment on the risk of mother to child transmission of Toxoplasma gondii. BJOG 2003, 110:112-120.
17. Gray J.J., Balfour A.H., Wreghitt T.G. Evaluation of a commercial latex agglutination test for detecting antibodies to Toxoplasma gondii. Serodiagnosis Immunother Infect Dis 1990, 4:335-340.
18. Haute Autorité de Santé (HAS). Surveillance sérologique et prévention de la toxoplasmose et de la rubéole au cours de la grossesse et dépistage prénatal de l'hépatite B - Pertinence des modalités de réalisationRecommandations en santé publique et Rapport d'orientation. Juillet 2009. www.HAS.fr http://www.has.fr/.
19. Holliman R.E., Johnson J., Duffy K., New L. Discrepant toxoplasma latex agglutination test results. J Clin Pathol 1989, 42:200-203.
20. Johnson J., Duffy K., New L., Holliman R.E., Chessum B.S., Fleck D.G. Direct agglutination test and other assays for measuring antibodies to Toxoplasma gondii. J Clin Pathol 1989, 42:536-541.
21. Lachaud L., Calas O., Picot M.C., Albaba S., Bourgeois N., Pratlong F. Value of 2 IgG avidity commercial tests used alone or in association to date toxoplasmosis contamination. Diagn Microbiol Infect Dis 2009, 64:267-274.
22. Le Pape P., Munoz U., Tromeur M.L., Marjolet M. Association d'un test au latex et d'une réaction d'hémagglutination indirecte pour le dépistage de la toxoplasmose. Feuillets de Biologie 1996, XXXVII:43-45.
23. Lecolier B., Pucheu B. Intérêt de l'étude de l'avidité des IgG pour le diagnostic de la toxoplasmose. Pathol Biol 1993, 41:155-158.
24. Liesenfeld O., Press C., Montoya J.G., Gill R., Isaac-Renton J.L., Hedman K., et al. False-positive results in immunoglobulin M (IgM) toxoplasma antibody tests and importance of confirmatory testing: the Platelia Toxo IgM test. J Clin Microbiol 1997, 35:174-178.
25. Montoya J.G., Liesenfeld O. Toxoplasmosis. Lancet 2004, 363:1965-1976.
26. Montoya J.G., Liesenfeld O., Kinney S., Press C., Remington J.S. VIDAS test for avidity of Toxoplasma-specific immunoglobulin G for confirmatory testing of pregnant women. J Clin Microbiol 2002, 40:2504-2508.
27. Montoya J.G., Remington J.S. Management of Toxoplasma gondii infection during pregnancy. Clin Infect Dis 2008, 47:554-566.
28. Reiter-Owona I., Petersen E., Joynson D., Aspök H., Darde M.L., Disko R., et al. The past and present role of the Sabin-Feldman dye test in the serodiagnosis of toxoplasmosis. Bull World Health Organ 1999, 77:923-935.
29. Robert R., Senet J.M., Senet J.M. Evaluation d'un test au latex sensibilisé par un antigène total pour le dépistage rapide des anticorps antitoxoplasmiques. Feuillets de Biologie 1984, XXV:33-36.
30. Sabin A.B., Feldman H.A. Dyes as microchemical indicators of a new immunity phenomenon affecting a protozoon parasite (Toxoplasma). Science 1948, 108:660-663.
31. Seguela J.P., Bessiere M.H., Foisy C., Launais B., Pozet S., Recco P., et al. Application de la réaction d'hémagglutination indirecte au sérodiagnostic de la toxoplasmose. Médecine et Maladies Infectieuses 1976, 8:268-274.
32. Senet J.M., Robert R. Hémagglutination indirecte utilisant un antigène particulaire appliquée au diagnostic immunologique de la toxoplasmose. Médecine et Maladies Infectieuses 1974, 4:21-22.
33. Stillwaggon E., Carrier C.S., Sautter M., McLeod R. Maternal serologic screening to prevent congenital toxoplasmosis: a decision-analytic economic model. PLoS Negl Trop Dis 2011, 5:e1333.
34. Villena I., Ancelle T., Delmas C., Garcia P., Brezin A.P., Thulliez P., et al. Congenital toxoplasmosis in France in 2007: first results from a national surveillance system. Euro Surveill 2010, 15.
35. Walton B.C., Benchoff B.M., Brooks W.H. Comparison of the indirect fluorescent antibody test and methylene blue dye test for detection of antibodies to Toxoplasma gondii. Am J Trop Med Hyg 1966, 15:149-152.